Cardiac Drugs in Pregnancy 2013
DOI: 10.1007/978-1-4471-5472-3_3
|View full text |Cite
|
Sign up to set email alerts
|

Managing Heart Failure Pre- and Postpartum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 26 publications
0
1
0
Order By: Relevance
“…(6,7) Unfortunately, pregnancy often masks symptoms and signs of heart failure, because it also causes shortness of breath and edema, delaying diagnosis. (8) Thus, in southern Africa, CVD represents an especially complex topic, usually underdiagnosed, poorly managed and insufficiently researched. Research shows that hypertensive disease, rheu- tional maternal mortality ratio (IMMR) went from 81 deaths per 100 000 live births in 2016 to 84 in 2019, highlighting the need for greater surveillance and a vigorous response to this increase.…”
Section: Introductionmentioning
confidence: 99%
“…(6,7) Unfortunately, pregnancy often masks symptoms and signs of heart failure, because it also causes shortness of breath and edema, delaying diagnosis. (8) Thus, in southern Africa, CVD represents an especially complex topic, usually underdiagnosed, poorly managed and insufficiently researched. Research shows that hypertensive disease, rheu- tional maternal mortality ratio (IMMR) went from 81 deaths per 100 000 live births in 2016 to 84 in 2019, highlighting the need for greater surveillance and a vigorous response to this increase.…”
Section: Introductionmentioning
confidence: 99%